ocrevus patient login

What is Ocrevus my Patient Solutions?

My Patient Solutions My Patient Solutions is an online tool that allows you the flexibility to work with OCREVUS Access Solutions and your OCREVUS Patient Navigator when it’s convenient for you. There are 2 versions of My Patient Solutions available for practices that treat OCREVUS patients. My Patient Solutions for Health Care Practices

How do patients sign the Ocrevus start form?

Complete the practice portion of the OCREVUS Start Form using eSignatures and either upload the signed patient authorization section or send patients a link by email to sign the form electronically.

How do I register for Ocrevus programs?

You can also call 1-844-OCREVUS (1-844-627-3887) to register. indicates programs available in Spanish/Disponible en español. Gabriel -. Pardo, MD

How is Ocrevus monitored during and after my infusion?

You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction. Tell your healthcare provider or nurse if you get any of these symptoms:

How long is immune system suppressed after OCREVUS?

A: The average half-life of ocrelizumab in the body is approximately 28 days. Following administration, B-cells are rapidly depleted and can remain undetectable for a prolonged and variable period of time ranging from 6 months to more than 12 months.

Is OCREVUS the best MS drug?

Hoffmann-La Roche-sponsored study found that Ocrevus outperformed placebos in patients with PPMS. Though the results were not as good as for relapsing-remitting MS, Hauser says, the drug did slow the progression of disability and myelin lesions.

What should I do before OCREVUS infusion?

Before your MS infusion, you want to be prepared to reduce side effects as much as possible. Being well-hydrated can help keep side effects at bay. Plan to also get a good night's sleep, follow your doctor's instructions for anything you should or shouldn't eat or drink, and any medication recommendations.

What is the OCREVUS copay program?

The OCREVUS Co-pay Program verifies the patient's information and notifies your practice when the card is loaded with the proper amount. Collect the patient's $5 co-pay for drug costs and/or $5 co-pay for infusion costs, then collect the rest of the patient's out-of-pocket costs for drug and/or infusion using the card.

How many years can you stay on Ocrevus?

This study is recruiting 600 people with either secondary or primary progressive MS. All participants will take Ocrevus​ every 24 weeks for four years. Progression of disability will be assessed using a combination of measures.

How did you feel after Ocrevus?

You may have fatigue (lack of energy) after receiving your Ocrevus infusion. It's likely you'll experience fatigue as an infusion side effect. Aside from lack of energy, other symptoms of fatigue may include: sore muscles.

Can I drive myself home after Ocrevus infusion?

are common and therefore we advise you not to drive yourself home after your infusion. The most common side effect of Ocrevus is infections. If you notice any signs of infection such as a cough, fever or herpes (cold sore, shingles and genital sores), please tell your General Practitioner.

Can I drink alcohol on Ocrevus?

Do not drive, use machinery, or do anything that needs alertness until you can do it safely. Limit alcoholic beverages. Talk to your doctor if you are using marijuana (cannabis). Ocrelizumab can make you more likely to get infections or may worsen any current infections.

How do you feel during Ocrevus infusion?

Fatigue. Some people may experience fatigue (lack of energy) while taking Ocrevus. In most cases, fatigue is an infusion side effect.

How do I get Ocrevus for free?

The Genentech Patient Foundation gives free OCREVUS to people who don't have insurance coverage or who have financial concerns.

Is Ocrevus covered by Medicare?

Government programs like Medicare and Medicaid are not commercial insurance. You may be able to use the OCREVUS Co-pay Program for your infusion costs if you are receiving OCREVUS from the Genentech Patient Foundation.

How do people afford MS treatment?

The Assistance Fund's MS Copay Assistance Program - 877-245-4412: The Assistance Fund's Multiple Sclerosis Insurance, Travel, and Incidental Medical Expenses will consider assisting with the cost of infusion administration costs when funding is available. Check their funding status here or call 855-263-1772.

How to contact Ocrevus?

For more information, go to www.OCREVUS.com or call 1-844-627-3887.

What is the registry for Ocrevus?

Pregnancy Registry. There is a pregnancy registry for women who take OCREVUS during pregnancy. If you become pregnant while receiving OCREVUS, tell your healthcare provider right away. Talk to your healthcare provider about registering with the OCREVUS Pregnancy Registry. The purpose of this registry is to collect information about your health and your baby’s health. Your healthcare provider can enroll you in this registry by calling 1-833-872-4370 or visiting www.ocrevuspregnancyregistry.com.

How long after ocrevus infusion do you have to be monitored?

You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction. Tell your healthcare provider or nurse if you get any of these symptoms: These infusion reactions can happen for up to 24 hours after your infusion.

What is ocrevus used for?

What is OCREVUS? OCREVUS is a prescription medicine used to treat: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Primary progressive MS, in adults. It is not known if OCREVUS is safe and effective in children.

When should you get your Ocrevus shots?

When possible, you should receive any ‘non-live’ vaccines at least 2 weeks before you start treatment with OCREVUS. If you would like to receive any non-live (inactivated) vaccines, including the seasonal flu vaccine, while you are being treated with OCREVUS, talk to your healthcare provider.

How long before you start treatment for ocrevus?

have had a recent vaccination or are scheduled to receive any vaccinations. You should receive any required ‘live’ or ‘live-attenuated’ vaccines at least 4 weeks before you start treatment with OCREVUS.

Can you get Ocrevus with PML?

Progressive Multifocal Leukoencephalopathy ( PML): Although no cases have been seen with OCREVUS treatment in clinical trials, PML may happen with OCREVUS. PML is a rare brain infection that usually leads to death or severe disability. Tell your healthcare provider right away if you have any new or worsening neurologic signs or symptoms. These may include problems with thinking, balance, eyesight, weakness on 1 side of your body, strength, or using your arms or legs.

How to register my patient solutions?

Go to the My Patient Solutions home screen and select REGISTER YOUR ACCOUNT in the top right corner.

What is my patient solution?

My Patient Solutions is an online tool that allows you the flexibility to work with OCREVUS Access Solutions and your OCREVUS Patient Navigator when it’s convenient for you. There are 2 versions of My Patient Solutions available for practices that treat OCREVUS patients.

How long is a link for a practice infusion valid?

Once the practice or infusion site has been registered, each user will receive an email within 2 business days to activate his or her account and create an individual login. This link will be valid for 30 days.

Does Ocrevus follow up with insurance?

Download the PA form (if available), request that OCREVUS Access Solutions follow up with the health insurance plan on behalf of the patient and view the status of the patient’s PA.

Welcome to the OCREVUS patient website

This website is intended only for patients who have been prescribed OCREVUS. It contains information about your condition, treatment with OCREVUS, patient support program as well as important safety information.

New patients

The information you are looking for is password protected. Please enter your access code to continue. Your access code will be provided by your healthcare professional.

HCP Login

If you are a healthcare professional who has previously registered on RocheInteract, please click on the button below to log in with your RocheInteract username and password.

About the OCREVUS Pregnancy Registry

The OCREVUS Pregnancy Registry is a global observational registry of women 18 years or older with MS who are pregnant and have received OCREVUS ® (ocrelizumab). This registry commenced in 2019. The goal is to enroll 290 ocrelizumab-exposed women, to observe 153 pregnancy outcomes.

Patient eligibility criteria

2 has not received ocrelizumab or any other MS disease-modifying therapy, except glatiramer acetate, at any time since 6 months before their last menstrual period.

Will I be compensated for my time as a healthcare provider?

You may be compensated for the time you spend on providing the information. The information that you provide will help us learn more about the possible effects of OCREVUS on pregnancy, delivery, and the health of infants whose mothers were exposed to OCREVUS during pregnancy.

How will the registry data be collected and stored?

Women who join the OCREVUS Pregnancy Registry will provide a release of information form that will allow the Registry Coordinating Center to contact their healthcare providers. These contacts are necessary to obtain information on the participant’s pregnancy and delivery, and/or the health of their infant.

How can I enroll my patient in the registry?

For the latest important safety information, please refer to the full Prescribing Information and Medication Guide. This is not intended to replace discussions with your healthcare provider.

What is the registry for Ocrevus?

Pregnancy Registry. There is a pregnancy registry for women who take OCREVUS during pregnancy. If you become pregnant while receiving OCREVUS, tell your healthcare provider right away. Talk to your healthcare provider about registering with the OCREVUS Pregnancy Registry. The purpose of this registry is to collect information about your health and your baby’s health. Your healthcare provider can enroll you in this registry by calling 1-833-872-4370or visiting www.ocrevuspregnancyregistry.com.

What to do if you have a baby and you have Ocrevus?

If you have a baby and you received OCREVUS during your pregnancy, it is important to tell your baby’s healthcare provider about receiving OCREVUS so they can decide when your baby should be vaccinated.

How long after birth control do you need to use ocrevus?

It is not known if OCREVUS will harm your unborn baby. You should use birth control (contraception) during treatment with OCREVUS and for 6 months after your last infusion of OCREVUS. Talk with your healthcare provider about what birth control method is right for you during this time.

When should you get your Ocrevus shots?

When possible, you should receive any ‘non-live’ vaccines at least 2 weeks before you start treatment with OCREVUS. If you would like to receive any non-live (inactivated) vaccines, including the seasonal flu vaccine, while you are being treated with OCREVUS, talk to your healthcare provider.

Can you have an allergic reaction to ocrevus?

Do notreceive OCREVUS if you have had a life-threatening allergic reaction to OCREVUS. Tell your healthcare provider if you have had an allergic reaction to OCREVUS or any of its ingredients in the past.

Can you breastfeed with ocrevus?

are breastfeeding or plan to breastfeed. It is not known if OCREVUS passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take OCREVUS.

Can Ocrevus be taken before or after other medicines?

Weakened immune system:OCREVUS taken before or after other medicines that weaken the immune system could increase your risk of getting infections.

Enrollment

Answer questions you or your patients may have throughout the enrollment process.

Benefits investigations (BIs)

Walk your patients through the results of their BIs and help them understand next steps.

To contact your Patient Navigator

The completion and submission of coverage- or reimbursement-related documentation are the responsibility of the patient and health care provider. Genentech makes no representation or guarantee concerning coverage or reimbursement for any service or item.

Financial Assistance Options

Genentech offers a variety of assistance options for your patients, based on certain eligibility criteria. Use the chart below to determine which assistance program may be right for your patient.

OCREVUS Co-pay Program

Genentech co-pay programs provide financial assistance to eligible commercially insured patients to help with their co-pays, co-insurance, or other out-of-pocket (OOP) costs.

Genentech Patient Foundation

The Genentech Patient Foundation helps people affected by serious medical conditions get the Genentech medicine they have been prescribed. If patients don’t have insurance coverage or have financial concerns and meet eligibility criteria, they may be able to get free medicine from the Genentech Patient Foundation.

Independent Co-pay Foundations

If eligible publicly or commercially insured patients have difficulty paying for their co-pay, co-insurance, or other out-of-pocket costs, Genentech Access Solutions can refer them to an independent co-pay assistance foundation supporting their diagnosis.